MICE SENSITIVITY ANALYSIS OF EVENT FREE SURVIVAL IN HIGH-RISK NEUROBLASTOMA PATIENTS RECEIVING EFLORNITHINE (DFMO) MAINTENANCE TREATMENT WITH MATCHED EXTERNAL CONTROLS

被引：0
|
作者：
Kraveka, Jacqueline [1 ]
Oesterheld, Javier [2 ]
Ferguson, William [3 ,4 ]
Bergendahl, Genevieve [5 ]
Clinch, Thomas [6 ]
Staines, Harry [6 ]
Sholler, Giselle Saulnier [2 ]
机构：
[1] MUSC Shawn Jenkins Childrens Hosp, Pediat Hematol Oncol, Charleston, SC USA
[2] Atrium Hlth Levine Childrens Hosp, Pediat Hematol & Oncol, Charlotte, NC USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
[4] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Dept Pediat, Div Hematol Oncol, St Louis, MO USA
[5] Beat Childhood Canc Res Consortium, Charlotte, NC USA
[6] US WorldMeds, Biostats, Louisville, KY USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP335
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma A Randomized Clinical Trial
    Park, Julie R.
    Kreissman, Susan G.
    London, Wendy B.
    Naranjo, Arlene
    Cohn, Susan Lerner
    Hogarty, Michael D.
    Tenney, Sheena C.
    Haas-Kogan, Daphne
    Shaw, Peter John
    Kraveka, Jacqueline M.
    Roberts, Stephen S.
    Geiger, James Duncan
    Doski, John J.
    Voss, Stephan D.
    Maris, John M.
    Grupp, Stephan A.
    Diller, Lisa
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (08): : 746 - 755
  • [22] Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients After Receiving Multimodality Treatment and Helical Tomotherapy
    Chen, Guann-Yiing
    Cheng, Jason Chia-Hsien
    Chen, Yu-Hsuan
    Lu, Meng-Yao
    Chang, Hsiu-Hao
    Yang, Yung-Li
    Jou, Shiann-Tarng
    Hsu, Wen-Ming
    Kuo, Sung-Hsin
    ANTICANCER RESEARCH, 2019, 39 (04) : 2207 - 2215
  • [23] A clinical observational study of dinutuximab beta as first-line maintenance treatment for patients with high-risk neuroblastoma in China
    Yu, Xuedi
    Kang, Suyi
    Ge, Junjie
    Wang, Jingfu
    BMC PEDIATRICS, 2025, 25 (01)
  • [24] Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients
    Gay, Andre N.
    Chang, Shirong
    Rutland, Lindsey
    Yu, Ling
    Byeseda, Sarah
    Naik-Mathuria, Bindi
    Cass, Darrell L.
    Russell, Heidi
    Olutoye, Oluyinka O.
    JOURNAL OF PEDIATRIC SURGERY, 2008, 43 (05) : 837 - 842
  • [25] Southwest Oncology Group S9921: Prolonged event-free survival in high-risk prostate cancer (PC) patients receiving adjuvant androgen deprivation
    Glode, L. M.
    Tangen, C. M.
    Hussain, M. H.
    Wood, D. P., Jr.
    Swanson, G. P.
    Quinn, D. I.
    Dawson, N.
    Balzer-Haas, N.
    Crawford, E. D.
    Thompson, I. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Axial Skeleton Radiomics of 18F-FDG PET/CT: Impact on Event-Free Survival Prediction in High-Risk Pediatric Neuroblastoma
    Feng, Lijuan
    Zhang, Shuxin
    Wang, Chaoran
    Li, Siqi
    Kan, Ying
    Wang, Chao
    Zhang, Hui
    Wang, Wei
    Yang, Jigang
    ACADEMIC RADIOLOGY, 2023, 30 (11) : 2487 - 2496
  • [27] Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
    Sun, Xiaofei
    Zhen, Zijun
    Guo, Ying
    Gao, Yuanhong
    Wang, Juan
    Zhang, Yu
    Zhu, Jia
    Lu, Suying
    Sun, Feifei
    Huang, Junting
    Cai, Ruiqing
    Zhang, Yizhuo
    Liu, Juncheng
    Xiao, Zizheng
    Zeng, Sihui
    Liu, Zhuowei
    CANCERS, 2021, 13 (14)
  • [28] Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
    Stigliani, Sara
    Croce, Michela
    Morandi, Fabio
    Scaruffi, Paola
    Rigo, Valentina
    Carlini, Barbara
    Manzitti, Carla
    Gigliotti, Anna Rita
    Tonini, Gian Paolo
    Pistoia, Vito
    Ferrini, Silvano
    Corrias, Maria Valeria
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [29] Long-Term Maintenance with Lenalidomide Improves Progression Free Survival In Myeloma Patients with High-Risk Cytogenetics: An IFM Study
    Avet-Loiseau, Herve
    Caillot, Denis
    Marit, Gerald
    Lauwers-Cances, Valerie
    Roussel, Murielle
    Facon, Thierry
    Hulin, Cyrille
    Lamy, Thierry
    Pegourie, Brigitte
    Maisonneuve, Herve
    Garderet, Laurent
    Moreau, Philippe
    Stoppa, Anne-Marie
    Dib, Mamoun
    Jaubert, Jerome
    Casassus, Philippe
    Mathiot, Claire
    Harousseau, Jean-Luc
    Moreau, Philippe
    Attal, Michel
    BLOOD, 2010, 116 (21) : 810 - 810
  • [30] Propensity score matched analysis of metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy or radical prostatectomy.
    Meeks, Marshall
    Markovina, Stephanie Subasic
    Vetter, Joel
    Paradis, Alethea
    Michalski, Jeff M.
    Sandhu, Gurdarshan Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345